Not all 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)

Background: Although the gastrointestinal stromal tumor (GIST) genotype is not currently included in risk-stratification systems, a growing body of evidence shows that the pathogenic variant (PV) type and codon location hold a strong prognostic influence on recurrence-free survival (RFS). This infor...

Full description

Bibliographic Details
Main Authors: Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, Bruno Vincenzi, Ida De Luca, Laura Algeri, Nadia Barraco, Chiara Brando, Annalisa Bonasera, Marco Bono, Marta Castiglia, Daniela Cancelliere, Massimiliano Cani, Lidia Rita Corsini, Alessia Fiorino, Antonio Galvano, Erika Pedone, Alessandro Perez, Alessia Pivetti, Giuseppa Graceffa, Gianni Pantuso, Daniela Cabibi, Antonio Russo, Viviana Bazan
Format: Article
Language:English
Published: SAGE Publishing 2021-09-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359211049779